med complex management Flashcards
precautions to take in patients with uncontrolled hypertension
avoid cox 2
avoid nsaids
avoid azoles with statins
avoid macrolides with ccb
caution vasoconstrictor eg avoid adrenaline containing retraction cord, topical vasoconstrictor for hemostasis
avoid intraligamentary, intraosseous, iv injection
aspirating syringe
what medication should i not give a patient who has recently undergone CABG
cox 2 inhibitors
nsaids
macrolides
azoles
how long to defer treatment by after cabg or ptca
3-6 months
defer by 1 year for elective surgical procedure
min 6 weeks for bare metal stent
6 months for drug eluting stent
how long to defer treatment by after AMI
3 months for routine treatment
6 months for invasive treatment, GA
precautions to take for a patient post ceid insertion
avoid diathermy electrocautery mri due to electromagnetic interference
defer by one month post insertion, ensure functional capacity is adequate
no antibiotic prophylaxis is required
avoid bupivacaine
caution vasoconstrictors
Patient is on clopidogrel for hypertension management. Needs to do extraction. What pre op planning needs to be done
Do not stop anti platelets
max dosage of adrenaline for patient with uncontrolled hypertension
0.04mg
why do we avoid azoles and macrolides in patients with htn
macrolides inhibit cytochrome, causing accumulation of statins and ccbs
azoles can increase the risk of statin associated myopathy
what is an acute hypertensive crisis
sudden severe increase in bp to ≥180/120mmHg
what should you check for if you suspect acute hypertensive crisis
dyspnea – pulmonary edema
chest discomfort – MI, aortic dissection
neurological deficit – stroke
nausea and vomiting – increased intracranial pressure
can you treat a patient with chest pains
Unstable angina eg occurs at rest, unresponsive to GTN – do not do elective dental treatment
stable angina eg only on exertion, relieved with rest and medication – treat with precautions such as stress reducing protocol, caution vasoconstrictor, avoid NSAIDs and COx2 inhibitors, GTN on standby
how long to defer treatment by afeer MI
if patient is deemed low risk, non invasive treatments can be deferred by 60 days
otherwise, non invasive treatment should be deferred by 3 months
invasive, surgical procedures should be deferred by 6 months
what medication is a patient on 3 months after PTCA? and what is my management?
dual anti platelets (high risk of stent thrombosis within first year of placement)
do not stop anti platelets, current recommendation is to not modify, though some may continue with aspirin and stop other anti platelet
avoid elective care for 6 months to 1 year. consult cardio for invasive procedure
> 3 exo, do over multiple visits
patient on dual anti platelet therapy will need to undergo major dental surgery. what to do?
stop p2y12 inhibitor 5-7 days prior to surgery, continue with aspirin unless bleeding risks prohibitive
restart 3 days after surgery
can i do routine dental treatment for a patient with an arrythmia?
yes (with stress reducing protocols, pain control, monitor pulse rate and pressure)
however, in some situations, treatment should be deferred
- symptomatic
- pre existing cardiac disease
- high grade av block
- ventricular arrhythmia
- supraventricular arrhythmia with uncontrolled ventricular rate
why do i need bleeding precautions in a patient with cardiac arrhythmia?
may be on warfarin or dabigatran or rivaroxaban due to increased risk of stroke
what medication to avoid in patients with cardiac arrhythmias
macrolides
azoles
bupivacaine
what does chads2 score mean
measures the thromboembolic risk in a patient with non valvular atrial fibrillation
congestive heart failure
hypertension
age>75
diabetes
stroke/tia
can i treat a patient with congestive heart failure?
nyha 1 and 2 can be treated. nyha 3 and 4 (marked limitation or unable to carry out physical activity) should not receive elective treatment
simplify treatment
bleeding precautions
minimise vasoconstrictors
avoid erythromycin, tetracycline if on digoxin
avoid nsaids, cox 2 inhibitors, corticosteroids (fluid retention)
consider terminating procedure if patient starts getting breathless
avoid supine position
signs of poor compensation for congestive heart failure
paroxysmal nocturnal dyspnea
orthopnea
dypsnea on exertion at level of activity that is usually well tolerated
peripheral edema
fluctuating body weight
when do symptoms of infective endocarditis develop
2 weeks after procedure
signs of infective endocarditis
fever in the presence of risk factors
- previous ie
- recent dental or surgical procedure
- congenital heart defect
- immunosuppression
- injection drug use
heart murmur
persistent bacteremia
immunological and emboli phenomenon
oral petechiae